Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Advances in chemotherapy of cancer in man.

Advances in cancer research

FARBER S, PINKEL D, SEARS EM, TOCH R.
PMID: 13381606
Adv Cancer Res. 1956;4:1-71. doi: 10.1016/s0065-230x(08)60721-6.

No abstract available.

Cite
FARBER S, PINKEL D, SEARS EM, et al. Advances in chemotherapy of cancer in man. Adv Cancer Res. 1956;4:1-71doi: 10.1016/s0065-230x(08)60721-6.
FARBER, S., PINKEL, D., SEARS, E. M., & TOCH, R. (1956). Advances in chemotherapy of cancer in man. Advances in cancer research, 41-71. https://doi.org/10.1016/s0065-230x(08)60721-6
FARBER, S, et al. "Advances in chemotherapy of cancer in man." Advances in cancer research vol. 4 (1956): 1-71. doi: https://doi.org/10.1016/s0065-230x(08)60721-6
FARBER S, PINKEL D, SEARS EM, TOCH R. Advances in chemotherapy of cancer in man. Adv Cancer Res. 1956;4:1-71. doi: 10.1016/s0065-230x(08)60721-6. PMID: 13381606.
Copy Download .nbib Format: NLM
The newer concept of cancer toxin.

Advances in cancer research

NAKAHARA W, FUKUOKA F.
PMID: 13533056
Adv Cancer Res. 1958;5:157-77. doi: 10.1016/s0065-230x(08)60411-x.

No abstract available.

Cite
NAKAHARA W, FUKUOKA F. The newer concept of cancer toxin. Adv Cancer Res. 1958;5:157-77doi: 10.1016/s0065-230x(08)60411-x.
NAKAHARA, W., & FUKUOKA, F. (1958). The newer concept of cancer toxin. Advances in cancer research, 5157-77. https://doi.org/10.1016/s0065-230x(08)60411-x
NAKAHARA, W, and FUKUOKA, F. "The newer concept of cancer toxin." Advances in cancer research vol. 5 (1958): 157-77. doi: https://doi.org/10.1016/s0065-230x(08)60411-x
NAKAHARA W, FUKUOKA F. The newer concept of cancer toxin. Adv Cancer Res. 1958;5:157-77. doi: 10.1016/s0065-230x(08)60411-x. PMID: 13533056.
Copy Download .nbib Format: NLM
Carcinogenic ability of .

Advances in cancer: research & treatment

Botelho MC, Veiga I, Oliveira PA, Lopes C, Teixeira M, da Costa JM, Machado JC.
PMID: 25221779
Adv Cancer Res Treat. 2013 Apr 28;2013.

No abstract available.

Cite
Botelho MC, Veiga I, Oliveira PA, et al. Carcinogenic ability of . Adv Cancer Res Treat. 2013;2013
Botelho, M. C., Veiga, I., Oliveira, P. A., Lopes, C., Teixeira, M., da Costa, J. M., & Machado, J. C. (2013). Carcinogenic ability of . Advances in cancer: research & treatment, 2013.
Botelho, Mónica C, et al. "Carcinogenic ability of ." Advances in cancer: research & treatment vol. 2013 (2013).
Botelho MC, Veiga I, Oliveira PA, Lopes C, Teixeira M, da Costa JM, Machado JC. Carcinogenic ability of . Adv Cancer Res Treat. 2013 Apr 28;2013. PMID: 25221779; PMCID: PMC4161036.
Copy Download .nbib Format: NLM
Racial and ethnic disparities in colorectal cancer incidence and mortality.

Advances in cancer research

Carethers JM.
PMID: 34148614
Adv Cancer Res. 2021;151:197-229. doi: 10.1016/bs.acr.2021.02.007. Epub 2021 May 05.

The occurrence of colorectal cancer (CRC) shows a large disparity among recognized races and ethnicities in the U.S., with Black Americans demonstrating the highest incidence and mortality from this disease. Contributors for the observed CRC disparity appear to be...

Cite
Carethers JM. Racial and ethnic disparities in colorectal cancer incidence and mortality. Adv Cancer Res. 2021;151:197-229doi: 10.1016/bs.acr.2021.02.007.
Carethers, J. M. (2021). Racial and ethnic disparities in colorectal cancer incidence and mortality. Advances in cancer research, 151197-229. https://doi.org/10.1016/bs.acr.2021.02.007
Carethers, John M. "Racial and ethnic disparities in colorectal cancer incidence and mortality." Advances in cancer research vol. 151 (2021): 197-229. doi: https://doi.org/10.1016/bs.acr.2021.02.007
Carethers JM. Racial and ethnic disparities in colorectal cancer incidence and mortality. Adv Cancer Res. 2021;151:197-229. doi: 10.1016/bs.acr.2021.02.007. Epub 2021 May 05. PMID: 34148614.
Copy Download .nbib Format: NLM
Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy.

Advances in cancer research

Ruiz-Bañobre J, Goel A.
PMID: 34148615
Adv Cancer Res. 2021;151:231-304. doi: 10.1016/bs.acr.2021.02.008. Epub 2021 Mar 29.

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States. Despite ongoing efforts aimed at increasing screening for CRC and early detection, and development of more effective therapeutic regimens, the overall morbidity and mortality...

Cite
Ruiz-Bañobre J, Goel A. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. Adv Cancer Res. 2021;151:231-304doi: 10.1016/bs.acr.2021.02.008.
Ruiz-Bañobre, J., & Goel, A. (2021). Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. Advances in cancer research, 151231-304. https://doi.org/10.1016/bs.acr.2021.02.008
Ruiz-Bañobre, Juan, and Goel, Ajay. "Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy." Advances in cancer research vol. 151 (2021): 231-304. doi: https://doi.org/10.1016/bs.acr.2021.02.008
Ruiz-Bañobre J, Goel A. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. Adv Cancer Res. 2021;151:231-304. doi: 10.1016/bs.acr.2021.02.008. Epub 2021 Mar 29. PMID: 34148615.
Copy Download .nbib Format: NLM
Unraveling the genomic landscape of colorectal cancer through mutational signatures.

Advances in cancer research

Díaz-Gay M, Alexandrov LB.
PMID: 34148618
Adv Cancer Res. 2021;151:385-424. doi: 10.1016/bs.acr.2021.03.003. Epub 2021 Mar 27.

Colorectal cancer, along with most other cancer types, is driven by somatic mutations. Characteristic patterns of somatic mutations, known as mutational signatures, arise as a result of the activities of different mutational processes. Mutational signatures have diverse origins, including...

Cite
Díaz-Gay M, Alexandrov LB. Unraveling the genomic landscape of colorectal cancer through mutational signatures. Adv Cancer Res. 2021;151:385-424doi: 10.1016/bs.acr.2021.03.003.
Díaz-Gay, M., & Alexandrov, L. B. (2021). Unraveling the genomic landscape of colorectal cancer through mutational signatures. Advances in cancer research, 151385-424. https://doi.org/10.1016/bs.acr.2021.03.003
Díaz-Gay, Marcos, and Alexandrov, Ludmil B. "Unraveling the genomic landscape of colorectal cancer through mutational signatures." Advances in cancer research vol. 151 (2021): 385-424. doi: https://doi.org/10.1016/bs.acr.2021.03.003
Díaz-Gay M, Alexandrov LB. Unraveling the genomic landscape of colorectal cancer through mutational signatures. Adv Cancer Res. 2021;151:385-424. doi: 10.1016/bs.acr.2021.03.003. Epub 2021 Mar 27. PMID: 34148618.
Copy Download .nbib Format: NLM
Some recent work on tumor immunity.

Advances in cancer research

GORER PA.
PMID: 13381609
Adv Cancer Res. 1956;4:149-86. doi: 10.1016/s0065-230x(08)60724-1.

No abstract available.

Cite
GORER PA. Some recent work on tumor immunity. Adv Cancer Res. 1956;4:149-86doi: 10.1016/s0065-230x(08)60724-1.
GORER, P. A. (1956). Some recent work on tumor immunity. Advances in cancer research, 4149-86. https://doi.org/10.1016/s0065-230x(08)60724-1
GORER, P A. "Some recent work on tumor immunity." Advances in cancer research vol. 4 (1956): 149-86. doi: https://doi.org/10.1016/s0065-230x(08)60724-1
GORER PA. Some recent work on tumor immunity. Adv Cancer Res. 1956;4:149-86. doi: 10.1016/s0065-230x(08)60724-1. PMID: 13381609.
Copy Download .nbib Format: NLM
Advances in Cancer Research: Centennial Volume. Introduction.

Advances in cancer research

Klein G, Vande Woude GF.
PMID: 18620090
Adv Cancer Res. 2008;100:v-vii. doi: 10.1016/S0065-230X(08)00008-0.

No abstract available.

Cite
Klein G, Vande Woude GF. Advances in Cancer Research: Centennial Volume. Introduction. Adv Cancer Res. 2008;100:v-viidoi: 10.1016/S0065-230X(08)00008-0.
Klein, G., & Vande Woude, G. F. (2008). Advances in Cancer Research: Centennial Volume. Introduction. Advances in cancer research, 100v-vii. https://doi.org/10.1016/S0065-230X(08)00008-0
Klein, George, and Vande Woude, George F. "Advances in Cancer Research: Centennial Volume. Introduction." Advances in cancer research vol. 100 (2008): v-vii. doi: https://doi.org/10.1016/S0065-230X(08)00008-0
Klein G, Vande Woude GF. Advances in Cancer Research: Centennial Volume. Introduction. Adv Cancer Res. 2008;100:v-vii. doi: 10.1016/S0065-230X(08)00008-0. PMID: 18620090.
Copy Download .nbib Format: NLM
Project PLACE: Enhancing community and academic partnerships to describe and address health disparities.

Advances in cancer research

Barrett NJ, Ingraham KL, Bethea K, Hwa-Lin P, Chirinos M, Fish LJ, Randolph S, Zhang P, Le P, Harvey D, Godbee RL, Patierno SR.
PMID: 32241388
Adv Cancer Res. 2020;146:167-188. doi: 10.1016/bs.acr.2020.01.009. Epub 2020 Mar 19.

Achieving cancer health equity is a national imperative. Cancer is the second leading cause of death in the United States and in North Carolina (NC), where the disease disproportionately impacts traditionally underrepresented race and ethnic groups, those who live...

Cite
Barrett NJ, Ingraham KL, Bethea K, et al. Project PLACE: Enhancing community and academic partnerships to describe and address health disparities. Adv Cancer Res. 2020;146:167-188doi: 10.1016/bs.acr.2020.01.009.
Barrett, N. J., Ingraham, K. L., Bethea, K., Hwa-Lin, P., Chirinos, M., Fish, L. J., Randolph, S., Zhang, P., Le, P., Harvey, D., Godbee, R. L., & Patierno, S. R. (2020). Project PLACE: Enhancing community and academic partnerships to describe and address health disparities. Advances in cancer research, 146167-188. https://doi.org/10.1016/bs.acr.2020.01.009
Barrett, Nadine J, et al. "Project PLACE: Enhancing community and academic partnerships to describe and address health disparities." Advances in cancer research vol. 146 (2020): 167-188. doi: https://doi.org/10.1016/bs.acr.2020.01.009
Barrett NJ, Ingraham KL, Bethea K, Hwa-Lin P, Chirinos M, Fish LJ, Randolph S, Zhang P, Le P, Harvey D, Godbee RL, Patierno SR. Project PLACE: Enhancing community and academic partnerships to describe and address health disparities. Adv Cancer Res. 2020;146:167-188. doi: 10.1016/bs.acr.2020.01.009. Epub 2020 Mar 19. PMID: 32241388; PMCID: PMC7526666.
Copy Download .nbib Format: NLM
Acetylcholinesterase and human cancers.

Advances in cancer research

Richbart SD, Merritt JC, Nolan NA, Dasgupta P.
PMID: 34353435
Adv Cancer Res. 2021;152:1-66. doi: 10.1016/bs.acr.2021.05.001. Epub 2021 Jun 21.

The enzyme acetylcholinesterase (AChE) is a serine hydrolase whose primary function is to degrade acetylcholine (ACh) and terminate neurotransmission. Apart from its role in synaptic transmission, AChE has several "non-classical" functions in non-neuronal cells. AChE is involved in cellular...

Cite
Richbart SD, Merritt JC, Nolan NA, et al. Acetylcholinesterase and human cancers. Adv Cancer Res. 2021;152:1-66doi: 10.1016/bs.acr.2021.05.001.
Richbart, S. D., Merritt, J. C., Nolan, N. A., & Dasgupta, P. (2021). Acetylcholinesterase and human cancers. Advances in cancer research, 1521-66. https://doi.org/10.1016/bs.acr.2021.05.001
Richbart, Stephen D, et al. "Acetylcholinesterase and human cancers." Advances in cancer research vol. 152 (2021): 1-66. doi: https://doi.org/10.1016/bs.acr.2021.05.001
Richbart SD, Merritt JC, Nolan NA, Dasgupta P. Acetylcholinesterase and human cancers. Adv Cancer Res. 2021;152:1-66. doi: 10.1016/bs.acr.2021.05.001. Epub 2021 Jun 21. PMID: 34353435.
Copy Download .nbib Format: NLM
Targeting heat shock protein 90 for anti-cancer drug development.

Advances in cancer research

Aswad A, Liu T.
PMID: 34353437
Adv Cancer Res. 2021;152:179-204. doi: 10.1016/bs.acr.2021.03.006. Epub 2021 Apr 20.

INTRODUCTION: Heat shock proteins (HSPs) constitute a large family of proteins involved in protein folding and maturation. HSP expression is induced by heat shock or other stressors including cellular damage and hypoxia. The major groups, which are classified based...

Cite
Aswad A, Liu T. Targeting heat shock protein 90 for anti-cancer drug development. Adv Cancer Res. 2021;152:179-204doi: 10.1016/bs.acr.2021.03.006.
Aswad, A., & Liu, T. (2021). Targeting heat shock protein 90 for anti-cancer drug development. Advances in cancer research, 152179-204. https://doi.org/10.1016/bs.acr.2021.03.006
Aswad, Anthony, and Liu, Tuoen. "Targeting heat shock protein 90 for anti-cancer drug development." Advances in cancer research vol. 152 (2021): 179-204. doi: https://doi.org/10.1016/bs.acr.2021.03.006
Aswad A, Liu T. Targeting heat shock protein 90 for anti-cancer drug development. Adv Cancer Res. 2021;152:179-204. doi: 10.1016/bs.acr.2021.03.006. Epub 2021 Apr 20. PMID: 34353437.
Copy Download .nbib Format: NLM
Protein Tyrosine Phosphatases: A new paradigm in an old signaling system?.

Advances in cancer research

Welsh CL, Pandey P, Ahuja LG.
PMID: 34353440
Adv Cancer Res. 2021;152:263-303. doi: 10.1016/bs.acr.2021.06.001. Epub 2021 Jul 08.

Protein Tyrosine Phosphatases reverse cellular signals initiated by growth factors receptors and other tyrosine kinases by dephosphorylating phosphotyrosine on target proteins. The activity of these enzymes is crucial for maintaining cell homeostasis, yet these enzymes have been often dismissed...

Cite
Welsh CL, Pandey P, Ahuja LG. Protein Tyrosine Phosphatases: A new paradigm in an old signaling system?. Adv Cancer Res. 2021;152:263-303doi: 10.1016/bs.acr.2021.06.001.
Welsh, C. L., Pandey, P., & Ahuja, L. G. (2021). Protein Tyrosine Phosphatases: A new paradigm in an old signaling system?. Advances in cancer research, 152263-303. https://doi.org/10.1016/bs.acr.2021.06.001
Welsh, Colin L, et al. "Protein Tyrosine Phosphatases: A new paradigm in an old signaling system?." Advances in cancer research vol. 152 (2021): 263-303. doi: https://doi.org/10.1016/bs.acr.2021.06.001
Welsh CL, Pandey P, Ahuja LG. Protein Tyrosine Phosphatases: A new paradigm in an old signaling system?. Adv Cancer Res. 2021;152:263-303. doi: 10.1016/bs.acr.2021.06.001. Epub 2021 Jul 08. PMID: 34353440.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries